The protection conferred by HSD17B13 rs72613567 on hepatic fibrosis is likely mediated by lowering ballooning and portal inflammation
| dc.contributor.author | Vilar-Gomez, Eduardo | |
| dc.contributor.author | Liang, Tiebing | |
| dc.contributor.author | Yates, Katherine | |
| dc.contributor.author | Wilson, Laura | |
| dc.contributor.author | Loomba, Rohit | |
| dc.contributor.author | Chalasani, Naga | |
| dc.contributor.department | Medicine, School of Medicine | |
| dc.date.accessioned | 2024-10-18T10:53:16Z | |
| dc.date.available | 2024-10-18T10:53:16Z | |
| dc.date.issued | 2023 | |
| dc.eprint.version | Author's manuscript | |
| dc.identifier.citation | Vilar-Gomez E, Liang T, Yates K, Wilson L, Loomba R, Chalasani N. The Protection Conferred by HSD17B13 rs72613567 on Hepatic Fibrosis Is Likely Mediated by Lowering Ballooning and Portal Inflammation. Clin Gastroenterol Hepatol. 2023;21(11):2981-2983.e3. doi:10.1016/j.cgh.2022.11.002 | |
| dc.identifier.uri | https://hdl.handle.net/1805/44062 | |
| dc.language.iso | en_US | |
| dc.publisher | Elsevier | |
| dc.relation.isversionof | 10.1016/j.cgh.2022.11.002 | |
| dc.relation.journal | Clinical Gastroenterology and Hepatology | |
| dc.rights | Publisher Policy | |
| dc.source | PMC | |
| dc.subject | Inflammation | |
| dc.subject | Liver cirrhosis | |
| dc.subject | Non-alcoholic fatty liver disease | |
| dc.title | The protection conferred by HSD17B13 rs72613567 on hepatic fibrosis is likely mediated by lowering ballooning and portal inflammation | |
| dc.type | Article |